Altimmune, Inc. (ALT) Tops Q3 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 22nd Century Group files prospectus for warrant share resale
• Laser Photonics regains NASDAQ compliance after filing quarterly report